Lysozyme amyloid: evidence for the W64R variant by proteomics in the absence of the wild type protein.

Moura, Alexandra; Nocerino, Paola; Gilbertson, Janet A; Rendell, Nigel B; Mangione, P Patrizia; Verona, Guglielmo; Rowczenio, Dorota; Gillmore, Julian D; Taylor, Graham W; Bellotti, Vittorio; Canetti, Diana

Moura, Alexandra; Nocerino, Paola; Gilbertson, Janet A; Rendell, Nigel B; Mangione, P Patrizia; Verona, Guglielmo; Rowczenio, Dorota; Gillmore, Julian D; Taylor, Graham W; Bellotti, Vittorio; Canetti, Diana.

Afiliación

Moura A; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Nocerino P; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Gilbertson JA; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Rendell NB; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Mangione PP; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Verona G; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy.
Rowczenio D; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Gillmore JD; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Taylor GW; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Bellotti V; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Canetti D; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.

Amyloid ; 27(3): 206-207, 2020 09.

Article en En | MEDLINE | ID: mdl-32067519

Asunto(s)

Amiloide/genética; Proteínas Amiloidogénicas/genética; Amiloidosis/genética; Proteómica; Amiloide/metabolismo; Amiloidosis/patología; Humanos; Muramidasa/genética; Muramidasa/metabolismo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteómica / Proteínas Amiloidogénicas / Amiloide / Amiloidosis Límite: Humans Idioma: En Revista: Amyloid Asunto de la revista: BIOQUIMICA Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google